X0303 4 2010-08-06 0 0001356857 Trius Therapeutics Inc TRSX 0001497522 KPCB PBD Founders Fund, LLC C/O KLEINER PERKINS CAUFIELD & BYERS 2750 SAND HILL ROAD MENLO PARK CA 94025 0 0 1 0 Common Stock 2010-08-06 4 C 0 6279 A 6279 D Common Stock 2010-08-06 4 C 0 2965 A 9244 D Common Stock 2010-08-06 4 P 0 4901 5.00 A 14145 D Series B Preferred Stock 2010-08-06 4 C 0 54000 0.00 D Common Stock 6279 0 D 8% Convertible Promissory Note 2010-08-06 4 C 0 2965 0.00 D Common Stock 2965 0 D Series B Preferred Stock was converted into shares of the Issuers Common Stock upon the consummation on the Issuer's initial Public Offering on an 8.6 for 1 basis. Principal and accrued interest was converted upon the Issuer's initial public offering into shares of Common Stock at a conversion price of 87.5% of the per share price of the Common Stock sold in the Issuer's initial public offering on August 6, 2010, at $5.00 per share. /s/ Theodore E. Schlein, Manager of KPCB PBD Associates, LLC, Manager of the Reporting Person 2010-08-06